Sustained clinical and epidemiological impact of Respiratory Syncytial Virus (RSV) in young infants exposed to universal immunization with Nirsevimab at birth: An Italian multicenter, retrospective, cohort study 2024/25

IF 11.9 1区医学 Q1 INFECTIOUS DISEASES

Journal of Infection Pub Date : 2025-10-03 DOI:10.1016/j.jinf.2025.106624

Paolo Manzoni, Matteo Riccò, Cecilia Nobili, Chryssoula Tzialla, Graziano Barera, Paolo Del Barba, Simona De Franco, Guido Pellegrini, Paola Magri, Enrico Crapanzano, Giangiacomo Nicolini, Andrea Alba, Stefano Fiocchi, Mauro Vivalda, Giulia Natta, Alessandra Casati, Mariano Manzionna, Simone Rugolotto, Laura Saggioro, Simona Pesce, Mario Giuffrè

引用次数: 0

查看原文本刊更多论文

“呼吸道合胞病毒（RSV）对出生时普遍接种Nirsevimab的婴儿的持续临床和流行病学影响：一项意大利多中心、回顾性、队列研究2024/25”。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of Infection 医学-传染病学

CiteScore

45.90

自引率

3.20%

发文量

475

审稿时长

16 days

期刊介绍： The Journal of Infection publishes original papers on all aspects of infection - clinical, microbiological and epidemiological. The Journal seeks to bring together knowledge from all specialties involved in infection research and clinical practice, and present the best work in the ever-changing field of infection. Each issue brings you Editorials that describe current or controversial topics of interest, high quality Reviews to keep you in touch with the latest developments in specific fields of interest, an Epidemiology section reporting studies in the hospital and the general community, and a lively correspondence section.